The research landscape for curing HIV has changed substantially since 2007. That was the year when Timothy Ray Brown, more commonly known as “the Berlin patient,” received his first transplant of stem cells comprising an HIV resistance gene. By 2011, he was generally considered cured.
The HIV of the still anonymous “London patient” was put into remission in early March of this year, 18 months after stopping antiretroviral therapy (ART). “A person